Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Selecting antithrombotic therapy for patients with atrial fibrillation.

Literature DB >> 25552627

Selecting antithrombotic therapy for patients with atrial fibrillation.

Christine Tanaka-Esposito¹, Mina K Chung².

Abstract

When considering anticoagulant therapy for patients with atrial fibrillation, one must balance the reduction in risk of thromboembolism that this therapy offers against the risk of bleeding that it poses. The American Heart Association, American College of Cardiology, and Heart Rhythm Society updated their atrial fibrillation guidelines in 2014. This review outlines a rationale for clinical decision-making based on the new guidelines and summarizes the currently approved drugs. Copyright

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 25552627 PMCID： PMC4444782 DOI： 10.3949/ccjm.82a.140002

Source DB: PubMed Journal: Cleve Clin J Med ISSN： 0891-1150 Impact factor: 2.321

74 in total

1. Dabigatran versus warfarin in patients with mechanical heart valves.

Authors: John W Eikelboom; Stuart J Connolly; Martina Brueckmann; Christopher B Granger; Arie P Kappetein; Michael J Mack; Jon Blatchford; Kevin Devenny; Jeffrey Friedman; Kelly Guiver; Ruth Harper; Yasser Khder; Maximilian T Lobmeyer; Hugo Maas; Jens-Uwe Voigt; Maarten L Simoons; Frans Van de Werf
Journal: N Engl J Med Date: 2013-08-31 Impact factor: 91.245

2. Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects.

Authors: Dagmar Kubitza; Michael Becka; Georg Wensing; Barbara Voith; Michael Zuehlsdorf
Journal: Eur J Clin Pharmacol Date: 2005-11-17 Impact factor: 2.953

3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors: Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal: Circulation Date: 2014-03-28 Impact factor: 29.690

Review 4. When patients on target-specific oral anticoagulants need surgery.

Authors: Mary Anderson; Kathryn L Hassell; Toby C Trujillo; Brian Wolfe
Journal: Cleve Clin J Med Date: 2014-10 Impact factor: 2.321

5. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes.

Authors: Laurent Azoulay; Sophie Dell'Aniello; Teresa A Simon; Christel Renoux; Samy Suissa
Journal: Eur Heart J Date: 2013-12-18 Impact factor: 29.983

6. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up.

Authors: Martin Osranek; Francesca Bursi; Kent R Bailey; Brandon R Grossardt; Robert D Brown; Stephen L Kopecky; Teresa S Tsang; James B Seward
Journal: Eur Heart J Date: 2005-09-01 Impact factor: 29.983

Selecting antithrombotic therapy for patients with atrial fibrillation.

1. Dabigatran versus warfarin in patients with mechanical heart valves.

2. Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects.

3. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Review 4. When patients on target-specific oral anticoagulants need surgery.

5. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes.

6. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up.

Review 7. Medical management after coronary stent implantation: a review.

Review 8. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban.

9. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor.

Review 10. Systematic overview of warfarin and its drug and food interactions.

Review 1. The critical care management of spontaneous intracranial hemorrhage: a contemporary review.